• Join
  • Achieve
  • Share
+44 7468277918

Conference Sessions

Home » Scientific Sessions

Conference Sessions

Immunology of Infection and Host Responses focuses on understanding how the immune system detects, responds to, and controls infectious agents. This field studies innate and adaptive immune mechanisms, signaling pathways, and cellular interactions that determine susceptibility and protection. It also explores immune evasion strategies employed by pathogens and the development of immunotherapies and vaccines. Key areas include host–pathogen interactions, immune memory, inflammation, and immune regulation. The goal is to uncover the mechanisms of immune defense, inform therapeutic interventions, and enhance strategies for preventing and controlling infectious diseases.

Vaccines: Development, Efficacy & Uptake focuses on the research, design, and implementation of vaccines to prevent infectious diseases. This field examines antigen discovery, immunogenicity, clinical trials, and strategies to optimize vaccine effectiveness and safety. It also explores factors influencing vaccine acceptance, coverage, and public health impact. Key areas include novel vaccine platforms, booster strategies, herd immunity, and global vaccination programs. The goal is to advance vaccine innovation, ensure high efficacy, and promote widespread uptake to reduce disease burden and protect population health.

Rapid Point-of-Care Diagnostic Technologies focuses on the development and application of fast, accurate, and accessible diagnostic tools for detecting infectious diseases at or near the site of patient care. This field explores innovations in biosensors, molecular assays, immunoassays, and portable devices to provide timely results. Key areas include sensitivity and specificity optimization, ease of use, cost-effectiveness, and integration into healthcare workflows. The goal is to enable early diagnosis, improve treatment outcomes, support outbreak management, and enhance healthcare delivery in diverse settings.

Next-Generation Sequencing for Pathogen Surveillance focuses on using advanced genomic technologies to detect, monitor, and characterize infectious agents. This field explores high-throughput sequencing methods to study viral, bacterial, fungal, and parasitic genomes, track pathogen evolution, and identify outbreaks in real time. Key areas include genomic epidemiology, antimicrobial resistance profiling, variant detection, and bioinformatics analysis. The goal is to enhance disease surveillance, improve public health responses, and enable precise, data-driven strategies for controlling infectious diseases globally.

One Health Approaches to Infectious Disease Control focuses on the interconnected health of humans, animals, and the environment in preventing and managing infectious diseases. This field examines how zoonotic pathogens, environmental changes, and human activities contribute to disease emergence and spread. It emphasizes integrated surveillance, cross-sectoral collaboration, and coordinated intervention strategies. Key areas include outbreak prediction, ecosystem health, veterinary public health, and policy development. The goal is to promote holistic, sustainable solutions for disease prevention, improve global health security, and reduce the impact of infectious threats across species and ecosystems.

Viral Pathogenesis and Immune Evasion focuses on understanding how viruses cause disease and evade host immune defenses. This field studies viral replication, virulence factors, and interactions with host cells and immune systems. It explores mechanisms such as immune suppression, antigenic variation, and latency that allow viruses to persist and spread. Key areas include virus–host interactions, antiviral response modulation, and the development of vaccines and therapeutics. The goal is to uncover viral strategies, enhance prevention and treatment approaches, and improve global management of viral infections.

Bacterial Pathogenesis and Host Interactions focuses on understanding how bacteria cause disease and interact with their hosts. This field examines bacterial virulence factors, infection strategies, and the molecular and cellular mechanisms that determine host susceptibility and immune responses. It also explores host–pathogen interactions, signaling pathways, and microbiome influences on health and disease. Key areas include infection models, immune evasion, and therapeutic targeting of bacterial processes. The goal is to uncover the mechanisms of bacterial disease, inform the development of new treatments, and improve strategies for prevention and control.

Antimicrobial Resistance (AMR) Mechanisms & Solutions focuses on understanding how microbes develop resistance to drugs and exploring strategies to combat this global health threat. This field studies the molecular, genetic, and biochemical mechanisms underlying resistance in bacteria, viruses, fungi, and parasites. It also emphasizes the development of novel therapeutics, alternative treatments, stewardship programs, and policy interventions. Key areas include surveillance of resistant strains, drug discovery, combination therapies, and mitigation of resistance spread. The goal is to preserve the effectiveness of existing antimicrobials, develop innovative solutions, and protect public health worldwide.

Clinical Microbiology and Diagnostic Innovations focuses on the identification, characterization, and management of infectious agents affecting human health. This field explores advances in microbial detection, laboratory diagnostics, and molecular techniques for accurate and timely disease diagnosis. It integrates studies on bacteria, viruses, fungi, and parasites with emerging technologies such as rapid testing, genomics, and point-of-care diagnostics. Key areas include antimicrobial susceptibility testing, quality assurance, and laboratory automation. The goal is to improve diagnostic accuracy, support effective clinical decision-making, and enhance patient care and infection control.

Emerging and Re-emerging Infectious Diseases focuses on the study of infectious agents that newly appear or reappear due to changes in ecology, human behavior, and pathogen evolution. This field examines viral, bacterial, parasitic, and fungal diseases, along with factors such as antimicrobial resistance, climate change, globalization, and population movement. It integrates research on disease surveillance, diagnostics, epidemiology, and host–pathogen interactions. Key areas include outbreak prediction, prevention strategies, vaccine and therapeutic development, and public health preparedness. The goal is to reduce disease burden, improve early detection and response, and strengthen global health systems to effectively manage infectious disease threats across diverse populations.

Public Health Policy and Infection Control Practices focuses on the development and implementation of strategies to prevent and control infectious diseases at the population level. This field examines evidence-based policies, regulatory frameworks, and best practices for infection prevention in healthcare and community settings. Key areas include vaccination programs, hygiene and sanitation measures, antimicrobial stewardship, surveillance systems, and outbreak management. The goal is to protect public health, reduce disease transmission, and ensure effective, sustainable infection control across diverse populations.

Global Infectious Disease Modeling & Prediction focuses on using mathematical, statistical, and computational approaches to understand, forecast, and manage the spread of infectious diseases worldwide. This field integrates epidemiological data, demographic factors, and environmental influences to simulate disease dynamics and assess intervention strategies. Key areas include predictive modeling, outbreak simulation, risk assessment, and scenario planning for pandemics and endemic diseases. The goal is to guide public health decision-making, optimize resource allocation, and strengthen global preparedness and response to infectious threats.

Innate Immunity and Interferon Responses focuses on the body’s first line of defense against infections and the critical role of interferons in antiviral protection. This field studies innate immune cells, pattern recognition receptors, signaling pathways, and the mechanisms by which interferons inhibit pathogen replication. Key areas include host–pathogen interactions, immune activation, and modulation of innate responses for therapeutic purposes. The goal is to understand early immune defenses, enhance antiviral strategies, and inform the development of immunotherapies and vaccines.

Bacteriophage Biology and Therapeutic Use focuses on the study of viruses that infect bacteria and their application in combating bacterial infections. This field examines phage life cycles, host specificity, genetics, and interactions with bacterial populations. Key areas include phage therapy development, antimicrobial resistance mitigation, bioengineering of phages, and clinical applications as alternatives or complements to antibiotics. The goal is to harness bacteriophages as effective, targeted therapeutics to treat bacterial infections and address the growing challenge of antimicrobial resistance.

Viral Evolution, Mutation & Variant Tracking focuses on understanding how viruses change over time and the implications for disease spread, severity, and control. This field studies viral genetics, mutation mechanisms, and the emergence of new variants, using genomic sequencing and bioinformatics tools. Key areas include monitoring viral evolution, assessing impacts on transmissibility and vaccine efficacy, and predicting potential outbreaks. The goal is to track viral changes, inform public health strategies, and guide the development of effective vaccines and therapeutics.

Healthcare-Associated Infections (HAIs) focuses on the prevention, detection, and management of infections acquired within healthcare settings. This field examines the epidemiology, risk factors, and transmission mechanisms of HAIs caused by bacteria, viruses, and fungi. Key areas include infection control practices, antimicrobial stewardship, surveillance, sterilization and disinfection protocols, and outbreak management. The goal is to reduce infection rates, improve patient safety, and enhance the overall quality of healthcare delivery.

Zoonotic Diseases: Surveillance and Control focuses on the detection, monitoring, and management of diseases transmitted between animals and humans. This field examines pathogen ecology, transmission dynamics, and risk factors associated with wildlife, livestock, and domestic animals. Key areas include integrated surveillance systems, early warning mechanisms, outbreak prevention, and implementation of control measures such as vaccination, biosecurity, and public health interventions. The goal is to reduce the impact of zoonotic diseases, protect human and animal health, and strengthen global preparedness for emerging infectious threats.

Outbreak Investigation & Response Strategies focuses on identifying, analyzing, and controlling infectious disease outbreaks to protect public health. This field examines epidemiological methods, surveillance systems, contact tracing, and risk assessment to detect and contain outbreaks efficiently. Key areas include field investigation, data analysis, emergency response planning, and implementation of control measures such as vaccination, quarantine, and community interventions. The goal is to enable rapid, evidence-based actions that minimize disease spread, reduce morbidity and mortality, and strengthen health system preparedness.

Bioinformatics & Computational Epidemiology focuses on applying computational and data-driven approaches to understand, predict, and manage infectious diseases. This field integrates genomic, proteomic, and epidemiological data to study pathogen evolution, transmission dynamics, and outbreak patterns. Key areas include modeling disease spread, genomic surveillance, network analysis, and development of predictive algorithms. The goal is to enhance disease monitoring, guide public health interventions, and support evidence-based decision-making for effective infectious disease control.

Antiviral and Antibiotic Therapeutics focuses on the discovery, development, and application of drugs to treat viral and bacterial infections. This field explores mechanisms of action, resistance, pharmacodynamics, and novel therapeutic strategies including combination therapies and targeted treatments. Key areas include drug design, preclinical and clinical evaluation, optimization of dosing regimens, and strategies to overcome antimicrobial resistance. The goal is to develop safe, effective, and sustainable treatments that reduce infection burden, improve patient outcomes, and support global health.

Ethics in Infectious Disease Research & Policy focuses on the moral, legal, and social considerations in studying, preventing, and managing infectious diseases. This field examines ethical issues in clinical trials, surveillance, data sharing, vaccine distribution, and public health interventions. Key areas include informed consent, equity, privacy, risk–benefit analysis, and policy decision-making. The goal is to ensure responsible research practices, protect human rights, and promote fair and ethical public health policies.

Infection Prevention in Low-Resource Settings focuses on strategies to reduce the burden of infectious diseases in areas with limited healthcare infrastructure. This field examines cost-effective interventions, hygiene and sanitation practices, community-based programs, and affordable diagnostic and treatment options. Key areas include education, vaccination campaigns, water and food safety, and infection control in healthcare facilities. The goal is to improve health outcomes, prevent disease spread, and strengthen public health systems in resource-limited environments.

Vector-Borne Diseases: Surveillance & Control focuses on the study and management of diseases transmitted by vectors such as mosquitoes, ticks, and flies. This field examines pathogen–vector–host interactions, transmission dynamics, and ecological factors influencing disease spread. Key areas include vector surveillance, control strategies, outbreak prediction, and implementation of preventive measures such as insecticides, vaccines, and public health campaigns. The goal is to reduce disease transmission, protect population health, and strengthen global preparedness against vector-borne infections.

Sexually Transmitted Infections: Prevention & Treatment focuses on understanding, diagnosing, and managing infections transmitted through sexual contact. This field examines pathogen biology, epidemiology, risk factors, and complications associated with STIs. Key areas include public health education, screening programs, antimicrobial therapy, vaccination, and behavioral interventions. The goal is to reduce transmission, improve patient outcomes, and promote sexual health through effective prevention and treatment strategies.

Tuberculosis and Other Mycobacterial Infections focuses on the biology, pathogenesis, diagnosis, and treatment of tuberculosis and related mycobacterial diseases. This field examines host–pathogen interactions, drug resistance mechanisms, and strategies for prevention, including vaccines and public health interventions. Key areas include clinical management, diagnostic innovations, antimicrobial therapy, and epidemiological surveillance. The goal is to reduce disease burden, improve patient outcomes, and enhance global control of mycobacterial infections.

Respiratory Viruses & Pandemic Preparedness focuses on the study of viruses that infect the respiratory tract and strategies to prevent, detect, and respond to potential pandemics. This field examines viral transmission, pathogenesis, immune responses, and epidemiology. Key areas include surveillance, vaccine and therapeutic development, outbreak modeling, and public health interventions. The goal is to enhance early detection, strengthen pandemic preparedness, and reduce the global impact of respiratory viral infections.

Clinical Trials for Anti-infective Agents focuses on the evaluation of new drugs, vaccines, and therapeutic interventions aimed at preventing or treating infectious diseases. This field examines trial design, safety assessment, efficacy testing, and regulatory compliance in preclinical and clinical settings. Key areas include dose optimization, patient selection, outcome measurement, and monitoring of adverse effects. The goal is to ensure the development of safe, effective, and evidence-based anti-infective agents that improve patient outcomes and support public health.

Host Genetics and Susceptibility to Infection focuses on understanding how genetic variation in humans influences the risk, severity, and outcome of infectious diseases. This field studies host genes involved in immune responses, pathogen recognition, and cellular defense mechanisms. Key areas include genome-wide association studies, functional genomics, and the identification of genetic factors that affect susceptibility or resistance to infections. The goal is to uncover genetic determinants of disease, inform personalized medicine approaches, and guide strategies for prevention and treatment of infectious diseases.

Environmental Reservoirs and Pathogen Ecology focuses on the study of natural and artificial habitats that harbor infectious agents and influence their survival, transmission, and evolution. This field examines the interactions between pathogens, hosts, and environmental factors such as water, soil, animals, and climate. Key areas include microbial ecology, environmental surveillance, risk assessment, and the impact of ecological changes on disease emergence. The goal is to understand pathogen ecology, predict outbreaks, and develop strategies to reduce the risk of environmentally mediated infections.

Transmission Dynamics and Contact Tracing focuses on understanding how infectious diseases spread within populations and implementing strategies to interrupt transmission. This field studies pathogen transmission patterns, reproduction numbers, and factors influencing infection spread. It also emphasizes the design and use of contact tracing, testing, and isolation measures to control outbreaks. Key areas include modeling transmission, identifying high-risk contacts, and evaluating intervention effectiveness. The goal is to limit disease spread, inform public health strategies, and enhance outbreak preparedness and response.